MediBeacon’s use of proprietary fluorescent tracer agents coupled with transdermal detection technology focuses on providing vital and actionable assessment of organ function.
Our Transdermal GFR Sensor (TGFR) is engineered for noninvasive detection of the change in levels of a fluorescent GFR tracer agent over time via a sensor placed on the patient’s skin. The TGFR Sensor measures the intensity of Lumitrace® fluorescence 2.5 times per second. The rate of change in the emitted fluorescence from Lumitrace is utilized to calculate a weighted average of the tGFR and displayed on the monitor.